Skip to Content

Assertio Holdings Inc ASRT

Morningstar Rating
$1.04 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ASRT is trading at a 617% premium.
Price
$1.05
Fair Value
$7.17
Uncertainty
Extreme
1-Star Price
$5.14
5-Star Price
$9.64
Economic Moat
Nnvnb
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ASRT is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.04
Day Range
$1.031.07
52-Week Range
$0.736.41
Bid/Ask
$1.03 / $1.10
Market Cap
$98.93 Mil
Volume/Avg
359,242 / 975,451

Key Statistics

Price/Earnings (Normalized)
3.14
Price/Sales
0.64
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
7.69%

Company Profile

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
30

Comparables

Valuation

Metric
ASRT
INVA
COLL
Price/Earnings (Normalized)
3.149.805.94
Price/Book Value
0.781.424.69
Price/Sales
0.644.372.45
Price/Cash Flow
3.118.115.18
Price/Earnings
ASRT
INVA
COLL

Financial Strength

Metric
ASRT
INVA
COLL
Quick Ratio
1.338.511.10
Current Ratio
1.8710.421.21
Interest Coverage
−96.259.812.42
Quick Ratio
ASRT
INVA
COLL

Profitability

Metric
ASRT
INVA
COLL
Return on Assets (Normalized)
8.43%14.79%19.65%
Return on Equity (Normalized)
15.37%29.29%117.94%
Return on Invested Capital (Normalized)
13.68%16.71%30.09%
Return on Assets
ASRT
INVA
COLL
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
LhmfxqrzhcFpdt$81.5 Bil
Merck KGaA ADR
MKKGY
BsvywmrsJdrtlq$80.4 Bil
Haleon PLC ADR
HLN
XzjqhccTxy$37.3 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
DtfvyhyPqjnf$19.1 Bil
Viatris Inc
VTRS
XhhvvnmqLmnq$12.7 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
DlvgmjgRpzq$12.0 Bil
Catalent Inc
CTLT
SzydyccjYkcfjl$10.1 Bil
Perrigo Co PLC
PRGO
LbtllgvyGtd$3.7 Bil
Prestige Consumer Healthcare Inc
PBH
XxrpmtmyTxdpyzp$3.3 Bil
Curaleaf Holdings Inc
CURLF
BgwphgcxSzks$3.2 Bil

Sponsor Center